Name: Express Scripts Holding Co. (NASDAQ:ESRX) | Analysis of Inventory
Creator: Stock Analysis on Net

Analysis of Inventory

Inventory Disclosure

Inventory Disclosure

Download chart

Express Scripts Holding Co., balance sheet: inventory

US$ in thousands

		Dec 31, 2017		Dec 31, 2016		Dec 31, 2015		Dec 31, 2014		Dec 31, 2013
	Prescription drugs and medical supplies	2,124,900)		1,959,000)		2,023,100)		2,113,200)		1,871,100)
	Inventories	2,124,900)		1,959,000)		2,023,100)		2,113,200)		1,871,100)

Based on: 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).

An analysis of the inventory levels from 2013 through 2017 reveals a period of fluctuation with a general upward trajectory over the five-year span. Total inventories are composed exclusively of prescription drugs and medical supplies, indicating a highly concentrated inventory profile centered entirely on core pharmaceutical and medical operations.

Inventory Composition: The total inventory value is identical to the value of prescription drugs and medical supplies across all reporting periods. This confirms that no other inventory categories, such as raw materials or work-in-progress, are recognized on the balance sheet.
Growth and Contraction Trends: A notable increase occurred between 2013 and 2014, with inventory rising from $1,871.1 million to $2,113.2 million. This growth was followed by a two-year period of gradual reduction, with values declining to $2,023.1 million in 2015 and further to $1,959.0 million in 2016.
Period-End Valuation: In 2017, a reversal of the previous downward trend was observed. Inventory levels rose to $2,124.9 million, representing the highest valuation within the five-year period analyzed.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?